These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 2862944)

  • 21. Effect of dopexamine hydrochloride on contractions of rabbit isolated aorta evoked by various agonists.
    Nedergaard OA
    Pharmacol Toxicol; 1994 Jan; 74(1):43-9. PubMed ID: 7909151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal vasodilatation by dopexamine and fenoldopam due to alpha 1-adrenoceptor blockade.
    Martin SW; Broadley KJ
    Br J Pharmacol; 1995 May; 115(2):349-55. PubMed ID: 7670737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anatomical localization of the binding and functional characterization of responses to dopexamine hydrochloride in the rat mesenteric vasculature.
    Amenta F; Ricci A; Napoleone P; Vyas SJ; Lokhandwala MF
    Pharmacology; 1991; 42(4):211-22. PubMed ID: 1677201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of presynaptic receptors in the cardiovascular actions of N,N-di-n-propyldopamine in the cat and dog.
    Massingham R; Dubocovich ML; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Oct; 314(1):17-28. PubMed ID: 7442823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of dopamine, (+/-)-dobutamine and the (-)-enantiomer of dobutamine with alpha- and beta-adrenoceptors in the pulmonary circulation of the dog.
    Shebuski RJ; Fujita T; Ruffolo RR
    Pharmacology; 1987; 34(4):201-12. PubMed ID: 3037572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The haemodynamic and myocardial effects of dopexamine: a new beta 2-adrenoceptor and dopaminergic agonist.
    Jaski BE; Wijns W; Foulds R; Serruys PW
    Br J Clin Pharmacol; 1986 Apr; 21(4):393-400. PubMed ID: 2871852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of dopamine on tracheal smooth muscle.
    Michoud MC; Amyot R; St-Jean S; Vaillancourt R
    Clin Exp Pharmacol Physiol; 1985; 12(1):51-9. PubMed ID: 4006311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of receptors mediating the effects of dopamine on gastric smooth muscle.
    Kurosawa S; Hasler WL; Torres G; Wiley JW; Owyang C
    Gastroenterology; 1991 May; 100(5 Pt 1):1224-31. PubMed ID: 1672857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal effects of dopamine and dopexamine in the newborn anesthetized rabbit.
    Jaton T; Thonney M; Gouyon JB; Guignard JP
    Life Sci; 1992; 50(3):195-202. PubMed ID: 1346227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine-induced relaxation of the guinea-pig isolated jejunum is not mediated through dopamine receptors.
    Lucchelli A; Boselli C; Grana E
    Pharmacol Res; 1990; 22(4):433-44. PubMed ID: 1976247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the pharmacological interventions to prevent oxygen free radical (OFR)-mediated toxicity; effects of dopexamine, a DA1 receptor and beta 2 adrenoceptor agonist.
    Jacinto SM; Lokhandwala MF; Jandhyala BS
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):277-83. PubMed ID: 7824044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for heterogeneity of prejunctional alpha-2-adrenoceptors.
    Oriowo MA; Hieble JP; Ruffolo RR
    Pharmacology; 1991; 43(1):1-13. PubMed ID: 1683709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog.
    Bass AS; Kohli JD; Lubbers N; Goldberg LI
    J Pharmacol Exp Ther; 1987 Sep; 242(3):940-4. PubMed ID: 2888876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the effects of dopexamine, a novel DA1 receptor and beta 2-adrenoceptor agonist, on cardiac function and splanchnic circulation in a canine model of hemorrhagic shock.
    Chintala MS; Moore RJ; Lokhandwala MF; Jandhyala BS
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):296-300. PubMed ID: 8097568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular pharmacology of adrenergic and dopaminergic receptors: therapeutic significance in congestive heart failure.
    Lokhandwala MF; Hegde SS
    Am J Med; 1991 May; 90(5B):2S-9S. PubMed ID: 1675549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopexamine hydrochloride in the human heart: receptor binding and effects on cAMP generation.
    Napoleone P; Ricci A; Ferrante F; Amenta F
    Eur Heart J; 1992 Dec; 13(12):1709-17. PubMed ID: 1363232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of dopexamine hydrochloride on calcium channels in isolated guinea pig ventricular myocytes.
    Dun W; Zhao RR; Liang Y; Wu BW
    Methods Find Exp Clin Pharmacol; 1996; 18(6):353-7. PubMed ID: 8892264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of 3H-noradrenaline accumulation by dopexamine hydrochloride in the isolated aorta of the rabbit.
    Nedergaard OA
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):270-3. PubMed ID: 2572974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular and renal haemodynamic effects of dopexamine: comparison with dopamine.
    Stephan H; Sonntag H; Henning H; Yoshimine K
    Br J Anaesth; 1990 Sep; 65(3):380-7. PubMed ID: 1977432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Agonistic actions of DPI (2-(3,4-dihydroxyphenylimino)-imidazolidine) on alpha-adrenoceptors and dopamine receptors.
    Woodman OL; Medgett IC; Lang WJ; Rand MJ
    Eur J Pharmacol; 1981 Oct; 75(1):11-9. PubMed ID: 6119208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.